vaccine development – mycolab.ai

Edible mushrooms as emerging biofactories for natural therapeutics and oral biopharmaceutical delivery

mycolabadmin

Mushrooms are emerging as natural medicine factories that can be genetically engineered to produce medications taken by mouth. Beyond their traditional use as health foods, scientists are now using advanced genetic techniques to program mushrooms to manufacture therapeutic proteins and vaccines. These engineered mushrooms can naturally package and protect these medications as they pass through the stomach, releasing them safely in the intestines for absorption. This approach offers a sustainable, affordable, and cold-chain-independent alternative to conventional injected medications.

Tailoring mRNA lipid nanoparticles for antifungal vaccines

mycolabadmin

Researchers are exploring mRNA vaccines, similar to those used for COVID-19, as a new approach to prevent fungal infections. These vaccines use fatty particles called lipid nanoparticles to deliver instructions to cells on how to make fungal proteins, triggering an immune response. The review discusses how to optimize these vaccines, what challenges need to be overcome, and why they might be especially useful for people with weakened immune systems who are most vulnerable to serious fungal infections.

Dendritic Cell-Based Therapeutic Immunization Induces Th1/Th17 Responses and Reduces Fungal Burden in Experimental Sporotrichosis

mycolabadmin

Researchers developed a vaccine using special immune cells called dendritic cells loaded with proteins from the fungus that causes sporotrichosis. When vaccinated mice were later infected with the fungus, they showed stronger immune responses and had lower levels of the fungus in their bodies. This suggests that dendritic cell-based vaccines could be a promising new treatment approach for sporotrichosis, a serious fungal infection that is difficult to treat with current medicines, especially in people with weakened immune systems.

Glycan microarray analysis of Candida-related antibodies in human and mice sera guides biomarker discovery and vaccine development

mycolabadmin

Researchers developed a test using synthetic sugar molecules found on Candida yeast to detect antibodies in blood from infected patients and mice. They discovered that the immune system produces different antibodies at different stages of infection, starting with antibodies against certain sugars and later focusing on others. The study identified three specific sugar structures that could be used to create simple blood tests to diagnose Candida infections and potentially develop vaccines to prevent these serious fungal infections.

Fungal vaccines: so needed, so feasible, and yet so far off

mycolabadmin

Fungal infections kill millions of people worldwide each year, particularly those with weakened immune systems, yet no vaccines exist to prevent them. Scientists have discovered that a specific fungal enzyme called Eng2 can trigger protective immune responses against three major disease-causing fungi. A vaccine containing this enzyme from all three fungi species could potentially protect against multiple dangerous fungal infections, though challenges like cost and the need to work in immunocompromised patients remain before such vaccines reach patients.

Things you wanted to know about fungal extracellular vesicles (but were afraid to ask)

mycolabadmin

Fungal extracellular vesicles are tiny particles released by fungal cells that play important roles in how fungi cause disease and how our immune system responds. These particles can either help fight infections or make them worse depending on the type of fungus and conditions involved. Scientists are discovering that these vesicles could potentially be used as vaccines and may explain why some antifungal drugs stop working.

Glycan microarray analysis of Candida-related antibodies in human and mice sera guides biomarker discovery and vaccine development

mycolabadmin

Researchers used a special microarray technology to identify immune responses in blood samples from people infected with Candida yeast. They found that early infections trigger antibodies against certain sugar structures, while later infections produce different antibodies. Three specific sugar molecules showed promise as markers for diagnostic tests and vaccine development against dangerous yeast infections.

Things you wanted to know about fungal extracellular vesicles (but were afraid to ask)

mycolabadmin

Fungal extracellular vesicles (EVs) are tiny packages released by fungal cells that play important roles in fungal infections and how our immune system responds to them. Scientists have confirmed these EVs are real biological structures, not laboratory artifacts, and discovered they are produced by many different fungal species. Interestingly, these EVs can have opposite effects on the immune system depending on the fungus involved—sometimes helping our bodies fight infection and sometimes making infections worse, making them both potential vaccines and virulence factors.

Fungal β-Glucans: Biological Properties, Immunomodulatory Effects, Diagnostic and Therapeutic Applications

mycolabadmin

β-glucans are natural substances found in yeast and fungi that help boost the immune system and fight cancer. They can be measured in blood to diagnose serious fungal infections and may help prevent common illnesses like colds and respiratory infections. Recent research suggests they could be useful additions to vaccines and may help patients recovering from COVID-19.

Research Topic: vaccine development